TSE:ACBAurora Cannabis Stock Price, Forecast & News

Aurora Cannabis' stock was trading at C$1.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ACB shares have increased by 1,547.0% and is now trading at C$19.27. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 2 sell ratings, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Aurora Cannabis.

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for Aurora Cannabis.

Aurora Cannabis Inc (TSE:ACB) issued its earnings results on Monday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The firm had revenue of $5.18 million for the quarter, compared to the consensus estimate of $7.44 million. View Aurora Cannabis' earnings history.

10 brokers have issued twelve-month target prices for Aurora Cannabis' shares. Their forecasts range from C$1.00 to C$24.00. On average, they expect Aurora Cannabis' share price to reach C$12.20 in the next year. This suggests that the stock has a possible downside of 36.7%. View analysts' price targets for Aurora Cannabis.

News stories about ACB stock have been trending negative on Monday, according to InfoTrie. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Aurora Cannabis earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutAurora Cannabis.

Some companies that are related to Aurora Cannabis include Hikma Pharmaceuticals (HIK), Evotec (EVT), Aphria (APHA), Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), OrganiGram (OGI), Hexo (HEXO), Next Science (NXS), HEXO (HEXO), ICC Labs (ICC), Benchmark (BMK), Amryt Pharma (AMYT), Green Organic Dutchman (TGOD) and WeedMD (WMD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), OrganiGram (OGI), Cronos Group (CRON), Green Organic Dutchman (TGOD), Micron Technology (MU), Alibaba Group (BABA) and Advanced Micro Devices (AMD).

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

One share of ACB stock can currently be purchased for approximately C$19.27.

Aurora Cannabis has a market capitalization of C$2.12 billion and generates C$295.36 million in revenue each year. Aurora Cannabis employs 967 workers across the globe.

The official website for Aurora Cannabis is auroramj.com.

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.